Stock Analysis on Net

Albemarle Corp. (NYSE:ALB)

$22.49

This company has been moved to the archive! The financial data has not been updated since May 3, 2023.

Return on Equity (ROE)
since 2005

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Albemarle Corp., ROE, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in thousands


The financial data over the period under review indicates fluctuating yet generally positive trends in profitability and equity growth. The net income attributable to the corporation shows notable volatility, with multiple peak and trough periods. Initial values show a steady increase from 2005 to 2007, followed by a dip in 2008 and 2009. A recovery phase is evident from 2010 to 2011, with another decline in 2014. Starting from 2015, net income experienced significant swings, including extraordinarily high values in 2016 and particularly in 2022, which stands out as an exceptional peak compared to previous years.

Total shareholders’ equity consistently increased throughout the timeline, demonstrating overall growth in the company’s net assets. Despite occasional decelerations in growth rates, especially between 2012 and 2014 where a downward adjustment is apparent from 2012’s high point, the equity base recovered strongly from 2015 onwards. This trend suggests effective retention of earnings and potential capital additions over the years, culminating in a substantial rise by the end of 2022.

The Return on Equity (ROE) metric exhibits considerable variability, reflecting the fluctuations in net income relative to shareholders’ equity. Initial years show moderate to strong ROE, peaking in 2011. However, this strong profitability is followed by a sharp decline around 2013 and a particularly low point in 2017. A dramatic rebound occurs in 2018 and onwards, with an exceptional ROE in 2022 that aligns with the extraordinary net income reported that year. These fluctuations indicate periods of varying efficiency in generating returns from shareholders’ investments, influenced by both operational performance and changes in equity levels.

In summary, the company demonstrates a pattern of growth in equity base accompanied by cyclical variations in profitability and efficiency. The strong equity growth coupled with variable net income and ROE suggests an adaptive business environment impacted by external and internal factors affecting earnings capacity. The significant spikes in both net income and ROE in the final year represent a marked departure from previous trends, indicating a year of remarkably high profitability and return efficiency.


Comparison to Competitors


Comparison to Sector (Chemicals)


Comparison to Industry (Materials)